Targeting programmed cell death in neurodegenerative diseases (original) (raw)

• Clarke, P. G. H. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181, 195–213 (1990).
  Article CAS Google Scholar
• Clarke, P. G. H. Cell death and diseases of the nervous system (eds Koliatsos, V. E. & Ratan, R. R.) 3–28 (Humana Press, New Jersey, 1999).
  Book Google Scholar
• Sperandio, S., de Belle, I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376–14381 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kane, D. J., Örd, T., Anton, R. & Bredesen, D. E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 269–275 (1995).
  Article CAS PubMed Google Scholar
• Sloviter, R. S. Apoptosis: a guide for the perplexed. Trends Pharmacol. Sci. 23, 19–24 (2002).
  Article CAS PubMed Google Scholar
• Kingsbury, A. E., Mardsen, C. D. & Foster, O. J. DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov. Disord. 13, 877–884 (1998).
  Article CAS PubMed Google Scholar
• Marx, J. New leads on the 'how' of Alzheimer's. Science 293, 2192–2194 (2001).
  Article CAS PubMed Google Scholar
• Graham, S. H. & Chen, J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 99–109 (2001).
  Article CAS PubMed Google Scholar
• Przedborski, S., Vila, M. & Jackson-Lewis, V. Neurodegeneration: what is it and where are we? J. Clin. Invest. 111, 3–10 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. & Dixit, V. M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926–2930 (1998).
  Article CAS PubMed Google Scholar
• Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489 (1997).
  Article CAS PubMed Google Scholar
• Gross, A., McDonnell, J. M. & Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899–1911 (1999).
  Article CAS PubMed Google Scholar
• Letai, A. et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183 (2002).
  Article CAS PubMed Google Scholar
• Marsden, V. S. et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419, 634–637 (2002).
  Article CAS PubMed Google Scholar
• Wyss-Coray, T. & Mucke, L. Inflammation in neurodegenerative disease — a double-edged sword. Neuron 35, 419–432 (2002).
  Article CAS PubMed Google Scholar
• Slee, E. A. Ordering the cytochrome _c_-initiated caspase cascade: hierarchical activation of caspase-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281–292 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Budihardjo, I., Oliver, H., Lutter, M., Luo, X. & Wang, X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269–290 (1999).
  Article CAS PubMed Google Scholar
• Du, C., Fang, M., Li, Y., Li, L. & Wang, X. Smac, a mitochondrial protein that promotes cytochrome _c_-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33–42 (2000).
  Article CAS PubMed Google Scholar
• Verhagen, A. M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53 (2000).
  Article CAS PubMed Google Scholar
• Chai, J. et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406, 855–862 (2000).
  Article CAS PubMed Google Scholar
• Srinivasula, S. M. et al. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol. Chem. 275, 36152–36157 (2000).
  Article CAS PubMed Google Scholar
• Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446 (1999).
  Article CAS PubMed Google Scholar
• Li, L. Y., Luo, X. & Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95–99 (2001).
  Article CAS PubMed Google Scholar
• Wang, X., Yang, C., Chai, J., Shi, Y. & Xue D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298, 1587–1592 (2002).
  Article CAS PubMed Google Scholar
• Nakagawa, T. et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98–103 (2000).
  Article CAS PubMed Google Scholar
• Morishima, N., Nakanishi, K., Takenouchi, H., Shibata, T. & Yasuhiko, Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome _c_-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277, 34287–34294 (2002).
  Article CAS PubMed Google Scholar
• Scorrano, L. et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003 Mar 6 (DOI 10.1126/science.1081208).
• Fahn, S. & Przedborski, S. Merritt's neurology (ed. Rowland, L. P) 679–693 (Lippincott, Williams & Wilkins, New York, 2000).
• Mochizuki, H., Goto, K., Mori, H. & Mizuno, Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120–123 (1996).
  Article CAS PubMed Google Scholar
• Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25–31 (1997).
  CAS PubMed Google Scholar
• Tatton, N. A., Maclean-Fraser, A., Tatton, W. G., Perl, D. P. & Olanow, C. W. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44, S142–S148 (1998).
  Article CAS PubMed Google Scholar
• Tompkins, M. M., Basgall, E. J., Zamrini, E. & Hill, W. D. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150, 119–131 (1997).
  CAS PubMed PubMed Central Google Scholar
• Kosel, S., Egensperger, R., Von Eitzen, U., Mehraein, P. & Graeber, M. B. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol. (Berl.) 93, 105–108 (1997).
  Article CAS Google Scholar
• Banati, R. B., Daniel, S. E. & Blunt, S. B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13, 221–227 (1998).
  Article CAS PubMed Google Scholar
• Wullner, U. et al. Cell death and apoptosis regulating proteins in Parkinson's disease — a cautionary note. Acta Neuropathol. (Berl.) 97, 408–412 (1999).
  Article CAS Google Scholar
• Hartmann, A. et al. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? J. Neurochem. 76, 1785–1793 (2001).
  Article CAS PubMed Google Scholar
• Tatton, N. A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166, 29–43 (2000).
  Article CAS PubMed Google Scholar
• Hartmann, A. et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 2875–2880 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hartmann, A. et al. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease. Neurobiol. Dis. 10, 28–32 (2002).
  Article CAS PubMed Google Scholar
• Hartmann, A. et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21, 2247–2255 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Viswanath, V. et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519–9528 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neurosci. 3, 1301–1306 (2000).
  Article CAS PubMed Google Scholar
• Hoglinger, G. U. et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84, 1–12 (2003).
  Article Google Scholar
• Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269 (2000).
  Article CAS PubMed Google Scholar
• van der Putten, H. et al. Neuropathology in mice expressing human α-synuclein. J. Neurosci. 20, 6021–6029 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Feany, M. B. & Bender, W. W. A Drosophila model of Parkinson's disease. Nature 404, 394–398 (2000).
  Article CAS PubMed Google Scholar
• Matsuoka, Y. et al. Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. 8, 535–539 (2001).
  Article CAS PubMed Google Scholar
• Lee, M. K. et al. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53-Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice PG-8968-73. Proc. Natl Acad. Sci. USA 99, 8968–73 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson-Lewis, V., Jakowec, M., Burke, R. E. & Przedborski, S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4, 257–269 (1995).
  Article CAS PubMed Google Scholar
• Tatton, N. A. & Kish, S. J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037–1048 (1997).
  Article CAS PubMed Google Scholar
• Vila, M. et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 2837–2842 (2001). Direct evidence indicating that the pro-PCD protein Bax is essential in MPTP-induced neurodegeneration.
  Article CAS PubMed PubMed Central Google Scholar
• Yang, L. et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. 18, 8145–8152 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Offen, D. et al. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA 95, 5789–5794 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M. & Manfredi, J. J. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21, 990–999 (2002).
  Article CAS PubMed Google Scholar
• Mandir, A. S. et al. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. J. Neurochem. 83, 186–192 (2002).
  Article CAS PubMed Google Scholar
• Mandir, A. S. et al. Poly (ADP-ribose) polymerase activation mediates MPTP-induced parkinsonism. Proc. Natl Acad. Sci. USA 96, 5774–5779 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Duan, W. et al. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann. Neurol. 52, 597–606 (2002). This study demonstrates that intraperitoneal injections of two p53 inhibitors attenuates Bax upregulation, improves motor function, reduces damage to nigrostriatal DA neurons and reduces depletion of DA and its metabolites in MPTP-treated mice.
  Article CAS PubMed Google Scholar
• Trimmer, P. A., Smith, T. S., Jung, A. B. & Bennett, J. P. Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 5, 233–239 (1996).
  Article CAS PubMed Google Scholar
• Saporito, M. S., Thomas, B. A. & Scott, R. W. MPTP activates c-Jun NH2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200–1208 (2000).
  Article CAS PubMed Google Scholar
• Xia, X. G. et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 10433–10438 (2001). Direct evidence of the involvement of the JNK/Jun pathway in MPTP-induced apoptotic cell death.
  Article CAS PubMed PubMed Central Google Scholar
• Saporito, M. S., Brown, E. M., Miller, M. S. & Carswell, S. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther. 288, 421–427 (1999).
  CAS PubMed Google Scholar
• Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome _c_-mediated death pathway. Science 288, 870–874 (2000).
  Article CAS PubMed Google Scholar
• Lei, K. et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun N-terminal kinase. Mol. Cell Biol. 22, 4929–4942 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Mochizuki, H. et al. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 10918–10923 (2001). Using viral vectors to deliver an Apaf1 inhibitor, this paper shows the instrumental role of the mitochondrial PCD pathway in MPTP-mediated neurodegeneration.
  Article CAS PubMed PubMed Central Google Scholar
• Eberhardt, O. et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 20, 9126–9134 (2000). Evidence indicating that adenoviral gene transfer of XIAP, a protein caspase inhibitor, can prevent cell death of DA neurons induced by MPTP, but it does not protect against MPTP-induced reduction of striatal cathecolamine concentrations.
  Article CAS PubMed PubMed Central Google Scholar
• Bilsland, J. et al. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci. 22, 2637–2649 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Raff, M. C., Whitmore, A. V. & Finn, J. T. Axonal self-destruction and neurodegeneration. Science 296, 868–871 (2002).
  Article CAS PubMed Google Scholar
• Chen, M. et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Med. 6, 797–801 (2000). Demonstration that inhibition of caspase activation by a second-generation tetracycline derivative delays disease progression and mortality in a transgenic mouse model of HD.
  Article CAS PubMed Google Scholar
• Du, Y. et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 14669–14674 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, D. C. et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763–1771 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047 (1997).
  Article CAS PubMed Google Scholar
• Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 107–108 (1998).
  Article Google Scholar
• Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
  Article CAS PubMed Google Scholar
• Vila, M. et al. α-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74, 721–729 (2000).
  Article CAS PubMed Google Scholar
• Przedborski, S. et al. Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637–640 (2001).
  Article CAS PubMed Google Scholar
• Dauer, W. et al. Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl Acad. Sci. USA 99, 14524–14529 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• El-Agnaf, O. M. et al. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440, 71–75 (1998).
  Article CAS PubMed Google Scholar
• Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T. & Masliah, E. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease. J. Biol. Chem. 274, 28849–28852 (1999).
  Article CAS PubMed Google Scholar
• Kakimura, J. et al. Release and aggregation of cytochrome c and α-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole. Eur. J. Pharmacol. 417, 59–67 (2001).
  Article CAS PubMed Google Scholar
• Riederer, P. et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515–520 (1989).
  Article CAS PubMed Google Scholar
• Nicole, A., Santiard-Baron, D. & Ceballos-Picot, I. Direct evidence for glutathione as mediator of apoptosis in neuronal cells. Biomed. Pharmacother. 52, 349–355 (1998).
  Article CAS PubMed Google Scholar
• Rowland, L. P. Merritt's textbook of neurology (ed. Rowland, L. P.) 742–749 (Lippincott, Williams & Wilkins, Philadelphia, 1995).
• Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
  Article CAS PubMed Google Scholar
• Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
  Article CAS PubMed Google Scholar
• Bruijn, L. I. et al. ALS-linked SOD1 mutant G85R mediated damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327–338 (1997).
  Article CAS PubMed Google Scholar
• Nagai, M. et al. Rats expressing human cytosolic copper–zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21, 9246–9254 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Subramaniam, J. R. et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nature Neurosci. 5, 301–307 (2002).
  Article CAS PubMed Google Scholar
• Reaume, A. G. et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13, 43–47 (1996).
  Article CAS PubMed Google Scholar
• Brown, R. H. Jr. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr. Opin. Neurobiol. 5, 841–846 (1995).
  Article CAS PubMed Google Scholar
• Rabizadeh, S. et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl Acad. Sci. USA 92, 3024–3028 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ghadge, G. D. et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 8756–8766 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Mena, M. A. et al. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69, 21–33 (1997).
  Article CAS PubMed Google Scholar
• Kostic, V., Jackson-Lewis, V., De Bilbao, F., Dubois-Dauphin, M. & Przedborski, S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559–562 (1997). Demonstration that overexpression of Bcl2 mitigates neurodegeneration and prolongs survival in a transgenic mouse model of familial ALS.
  Article CAS PubMed Google Scholar
• Li, M. et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335–339 (2000). Demonstration that the irreversible broad-caspase inhibitor zVAD-fmk attenuates mutant SOD1-mediated cell death in a transgenic mouse model of ALS, resulting in a delayed disease onset and mortality.
  Article CAS PubMed Google Scholar
• Guegan, C. & Przedborski, S. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 111, 153–161 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Cleveland, D. W. & Rothstein, J. D. From Charcot to Lou Gehrig deciphering selective motor neuron death in ALS. Nature Rev. Neurosci. 2, 806–819 (2001).
  Article CAS Google Scholar
• Hirano, A. Aspects of the ultrastructure of amyotrophic lateral sclerosis. Adv. Neurol. 36, 75–88 (1982).
  CAS PubMed Google Scholar
• Martin, L. J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58, 459–471 (1999).
  Article CAS PubMed Google Scholar
• Vukosavic, S. et al. Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20, 9119–9125 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Pasinelli, P., Houseweart, M. K., Brown, R. H. Jr & Cleveland, D. W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 13901–13906 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Dal Canto, M. C. & Gurney, M. E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145, 1271–1279 (1994).
  CAS PubMed PubMed Central Google Scholar
• Yoshiyama, Y., Yamada, T., Asanuma, K. & Asahi, T. Apoptosis related antigen, LeY and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 88, 207–211 (1994).
  Article CAS Google Scholar
• Ekegren, T., Grundstrom, E., Lindholm, D. & Aquilonius, S. M. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol. Scand. 100, 317–321 (1999).
  Article CAS PubMed Google Scholar
• Migheli, A., Cavalla, P., Marino, S. & Schiffer, D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53, 606–616 (1994).
  Article CAS PubMed Google Scholar
• Migheli, A. et al. Lack of apoptosis in mice with ALS. Nature Med. 5, 966–967 (1999).
  Article CAS PubMed Google Scholar
• He, B. P. & Strong, M. J. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits. Neuropathol. Appl. Neurobiol. 26, 150–160 (2000).
  Article CAS PubMed Google Scholar
• Pedersen, W. A., Luo, H., Kruman, I., Kasarskis, E. & Mattson, M. P. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J. 14, 913–924 (2000).
  Article CAS PubMed Google Scholar
• Mu, X., He, J., Anderson, D. W., Trojanowski, J. Q. & Springer, J. E. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379–386 (1996).
  Article CAS PubMed Google Scholar
• Vukosavic, S., Dubois-Dauphin, M., Romero, N. & Przedborski, S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 73, 2460–2468 (1999).
  Article CAS PubMed Google Scholar
• Troost, D., Aten, J., Morsink, F. & De Jong, J. M. B. V. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post- central gyrus. Neuropathol. Appl. Neurobiol. 21, 498–504 (1995).
  Article CAS PubMed Google Scholar
• Gonzalez de Aguilar, J. L. et al. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol. Dis. 7, 406–415 (2000).
  Article CAS PubMed Google Scholar
• Guegan, C., Vila, M., Rosoklija, G., Hays, A. P. & Przedborski, S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21, 6569–6576 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Martin, L. J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7, 613–622 (2000).
  Article CAS PubMed Google Scholar
• Prudlo, J. et al. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res. 879, 183–187 (2000).
  Article CAS PubMed Google Scholar
• Kuntz, C., Kinoshita, Y., Beal, M. F., Donehower, L. A. & Morrison, R. S. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 165, 184–190 (2000).
  Article CAS PubMed Google Scholar
• Guegan, C. et al. Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 20, 553 (2002).
  Article CAS PubMed Google Scholar
• Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J. & Yuan, J. Inhibition of ICE slows ALS in mice. Nature 388, 31 (1997).
  Article CAS PubMed Google Scholar
• Zhu, S. et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74–78 (2002). Demonstration that minocycline prevents mitochondrial release of cytochrome c , resulting in a delayed disease onset and extended survival of transgenic ALS mice.
  Article CAS PubMed Google Scholar
• Ishigaki, S. et al. X-Linked inhibitor of apoptosis protein is involved in mutant SOD1- mediated neuronal degeneration. J. Neurochem. 82, 576–584 (2002).
  Article CAS PubMed Google Scholar
• Raoul, C., Henderson, C. E. & Pettmann, B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 1049–1062 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Raoul, C. et al. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067–1083 (2002).
  Article CAS PubMed Google Scholar
• Nguyen, M. D., Julien, J. P. & Rivest, S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1β in neurodegeneration. Ann. Neurol. 50, 630–639 (2001).
  Article CAS PubMed Google Scholar
• Brandt, J. et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46, 527–531 (1996).
  Article CAS PubMed Google Scholar
• Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
  Article CAS PubMed Google Scholar
• Thomas, L. B. et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133, 265–272 (1995).
  Article CAS PubMed Google Scholar
• Portera-Cailliau, C., Hedreen, J. C., Price, D. L. & Koliatsos, V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775–3787 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263–267 (1999).
  Article CAS PubMed Google Scholar
• Sanchez, I. et al. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623–633 (1999).
  Article CAS PubMed Google Scholar
• Andreassen, O. A. et al. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. J. Neurochem. 75, 847–852 (2000).
  Article CAS PubMed Google Scholar
• Duan, W. et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl Acad. Sci. USA 100, 2911–2916 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Miyashita, T. et al. Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem. Biophys. Res. Commun. 257, 724–730 (1999).
  Article CAS PubMed Google Scholar
• Rigamonti, D. et al. Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 14545–14548 (2001).
  Article CAS PubMed Google Scholar
• Goldberg, Y. P. et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442–449 (1996).
  Article CAS PubMed Google Scholar
• Wellington, C. L. et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158–9167 (1998).
  Article CAS PubMed Google Scholar
• Wellington, C. L. et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831–19838 (2000).
  Article CAS PubMed Google Scholar
• Martindale, D. et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18, 150–154 (1998).
  Article CAS PubMed Google Scholar
• DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075–1081 (1995).
  Article CAS PubMed Google Scholar
• Kim, Y. J. et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl Acad. Sci. USA 98, 12784–12789 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mende-Mueller, L. M., Toneff, T., Hwang, S. R., Chesselet, M. F. & Hook, V. Y. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J. Neurosci. 21, 1830–1837 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wellington, C. L. et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862–7872 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gervais, F. G. et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nature Cell Biol. 4, 95–105 (2002).
  Article CAS PubMed Google Scholar
• Nicholson, D. W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000).
  Article CAS PubMed Google Scholar
• Loo, D. T. et al. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. USA 90, 7951–7955 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Su, J. H., Anderson, A. J., Cummings, B. J. & Cotman, C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5, 2529–2533 (1994).
  Article CAS PubMed Google Scholar
• Stadelmann, C. et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155, 1459–1466 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Selznick, L. A. et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 1020–1026 (1999).
  Article CAS PubMed Google Scholar
• Rohn, T. T., Head, E., Nesse, W. H., Cotman, C. W. & Cribbs, D. H. Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol. Dis. 8, 1006–1016 (2001).
  Article CAS PubMed Google Scholar
• Rohn, T. T. et al. Caspase-9 Activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11, 341–354 (2002).
  Article CAS PubMed Google Scholar
• Ivins, K. J., Thornton, P. L., Rohn, T. T. & Cotman, C. W. Neuronal apoptosis induced by β-amyloid is mediated by caspase-8. Neurobiol. Dis. 6, 440–449 (1999).
  Article CAS PubMed Google Scholar
• Giovanni, A. et al. E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275, 11553–11560 (2000).
  Article CAS PubMed Google Scholar
• Troy, C. M. et al. Caspase-2 mediates neuronal cell death induced by β-amyloid. J. Neurosci. 20, 1386–1392 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gervais, F. G. et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 97, 395–406 (1999).
  Article CAS PubMed Google Scholar
• Lu, D. C. et al. A second cytotoxic proteolytic peptide derived from amyloid-β protein precursor. Nature Med. 6, 397–404 (2000).
  Article CAS PubMed Google Scholar
• Langston, J. W., Ballard, P. & Irwin, I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979–980 (1983).
  Article CAS PubMed Google Scholar
• Nicklas, W. J., Yougster, S. K., Kindt, M. V. & Heikkila, R. E. MPTP, MPP+ and mitochondrial function. Life Sci. 40, 721–729 (1987).
  Article CAS PubMed Google Scholar
• Gluck, M. R., Youngster, S. K., Ramsay, R. R., Singer, T. P. & Nicklas, W. J. Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles. J. Neurochem. 63, 655–661 (1994).
  Article CAS PubMed Google Scholar
• Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62 (1993).
  Article CAS PubMed Google Scholar
• Deng, H. -X. et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047–1051 (1993).
  Article CAS PubMed Google Scholar
• Chiu, A. Y. et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6, 349–362 (1995).
  Article CAS PubMed Google Scholar
• Dal Canto, M. C. & Gurney, M. E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676, 25–40 (1995).
  Article CAS PubMed Google Scholar
• Almer, G., Vukosavic, S., Romero, N. & Przedborski, S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415–2425 (1999).
  Article CAS PubMed Google Scholar
• Tu, P. H. et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl Acad. Sci. USA 93, 3155–3160 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Teismann, P et al. Cyclooxygenase-2 is instrumental in Parkinson disease neurodegeneration. Proc. Natl Acad. Sci. USA (in the press).